Churg-Strauss syndrome: Clinical and serological features of 19 patients from a single Italian centre

Rheumatology

Volumn 41, Issue 11, 2002, Pages 1286-1294

  Della Rossa, A ^a,d   Baldini, C ^a   Tavoni, A ^a   Tognetti, A ^b   Neglia, D ^c   Sambuceti, G ^c   Puccini, R ^b   Colangelo, C ^a   Bombardieri, S ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^d NONE   (Italy)

Author keywords

Churg Strauss syndrome; Italian centre; Long term follow up; Retrospective study; Treatment

Indexed keywords

AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; METHOTREXATE; METHYLPREDNISOLONE; NEUTROPHIL CYTOPLASMIC ANTIBODY; STEROID;

ADULT; AGED; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CHURG STRAUSS SYNDROME; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; GASTROINTESTINAL DISEASE; HEART DISEASE; HUMAN; HYPEREOSINOPHILIA; ITALY; LUNG DISEASE; MALE; MUSCULOSKELETAL DISEASE; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SEROLOGY; SKIN DISEASE; TREATMENT OUTCOME; VASCULITIS;

ADULT; AGED; AZATHIOPRINE; BIOPSY, NEEDLE; CHURG-STRAUSS SYNDROME; CYCLOPHOSPHAMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; INFUSIONS, INTRAVENOUS; ITALY; MALE; METHOTREXATE; METHYLPREDNISOLONE; MIDDLE AGED; PULSE THERAPY, DRUG; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0036851421     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Churg J, Strauss L. Allergic granulomatosis, allergic angiitis and polyarteritis nodosa. Am J Pathol 1951;27:277-301.
2. Fauci AS, Haynes BF, Katz P. The spectrum of vasculitis: clinical, pathologic, immunologic and therapeutic considerations. Ann Intern Med 1978;89:660-76.
3. Lanham JG, Elkon KB, Pusey CD, Hughes GR. Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine 1984;63:65-81.
4. Watts RA, Carrutthers DM, Scott DG. Epidemiology of systemic vasculitis: changing incidence or definition? Semin Arthritis Rheum 1998;25:28-34.
5. Haugeberg G, Bie R, Bendvold A, Larsen AS, Johnson V. Primary vasculitis in a Norwegian community hospital. A retrospective study. Clin Rheumatol 1998;17:364-8.
6. Solans R, Bosch JA, Perez-Bocanegra C et al. Churg-Strauss syndrome: outcome and long-term follow-up of 32 patients. Rheumatology 2001;40:763-71.
7. Chumbley LC, Harrison EG Jr, DeRemee RA. Allergic granulomatosis and angiitis (Churg-Strauss syndrome). Report and analysis of 30 cases. Mayo Clin Proc 1994; 52:477-84.
8. Gaskin G, Clutterbuck EJ, Pusey CD. Renal disease in the Churg-Strauss syndrome. Diagnosis management and outcome. Contrib Nephrol 1991;94:58-65.
9. Abu-Shakra M, Smythe H, Lewtas J, Badley E, Weber D, Keystone E. Outcome of polyarteritis nodosa and Churg-Strauss syndrome. An analysis of twenty-five patients. Arthritis Rheum 1994;37:1798-803.
10. Savige J, Gillis D, Benson E et al. International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). Am J Clin Pathol 1999;111:507-13.
11. Valeri A, Radhakrishnam J, Estes D et al. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective 5-year study. Clin Nephrol 1994;42:71-8.
12. Gourley MF, Austin HA 3rd, Scott D et al. Methylprednisolone and cyclophosphamide alone or in combination in patients with lupus nephritis. A randomised control trial. Ann Intern Med 1996;125:549-57.
13. Luqmani RA, Bacon PA, Moots RJ et al. Birmingham vasculitis activity score (BVAS) in systemic necrotizing vasculitis. Q J Med 1994;87:671-8.
14. Hunder GG, Arend WP, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis: Introduction. Arthritis Rheum 1990; 33:1065-7.
15. Masi AT, Hunder GG, Lie JT et al. The American College of Rheumatology criteria for the classification of Churg Strauss (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33:1094-2000.
16. Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome: clinical study and long term follow-up of 96 patients. Medicine 1999; 78:26-37.
17. Lhote F, Cohen P, Guillevin L. Polyarteritis nodosa, microscopic polyangitis and Churg-Strauss syndrome. Lupus 1998;7:238-58.
18. Eustace JA, Nadasdy T, Choi M. The Churg-Strauss syndrome. J Am Soc Nephrol 1999;10:2048-55.
19. Hattori N, Ichimura M, Nagamatsu M et al. Clinicopathological features of Churg-Strauss syndrome associated neuropathy. Brain 1999;122:427-39.
20. Boggi U, Mosca M, Giulianotti PC, Naccarato AG, Bombardieri S, Mosca F. Surviving catastrophic gastrointestinal involvement due to Churg-Strauss syndrome: report of a case. Hepatogastroenterology 1997;44:1169-71.
21. Hasley P, Follansbee W, Coulehan J. Cardiac manifestations of Churg-Strauss syndrome: report of a case and review of the literature. Am Heart J 1990;120:996-9.
22. Kozak M, Gill E, Green L. The Churg-Strauss syndrome: a case report with angiographically documented coronary involvement and a review of the literature. Chest 1995;107:578-80.
23. Hellemans S, Dens J, Knockaert D. Coronary involvement in the Churg-Strauss syndrome. Heart 1997;77:576-8.
24. Hwang B, Liu RS, Chu LS, Lee PC, Lu JH, Meng LC. Positron emission tomography for the assessment of myocardial viability in Kawasaki's disease using different therapies. Nucl Med Commun 2000;21:631-6.
25. Yoshibayashi M, Tamaki N, Nishioka K et al. Regional myocardial perfusion and metabolism assessed by positron emission tomography in children with Kawasaki's disease and significance of abnormal Q waves and their disappearance. Am J Cardiol 1991;15:1638-45.
26. Richer C, Mouthon L, Cohen P et al. IgA glomerulonephritis associated with microscopic polyangiitis or Churg-Strauss syndrome. Clin Nephrol 1999; 52:47-50.
27. Haas M, Jafri J, Bartosh SM, Adler SG, Meehan SM. ANCA associated crescentic glomerulonephritis with mesangial IgA deposits. Am J Kidney Dis 2000; 36:709-18.
28. Nishika K, Chikazawa H, Matsumori A et al. Antimyeloperoxidase and anti-lactoferrin antibodies in patients with IgA nephropathy and Henoch Schonlein purpura. Rynsho Byori 1999;47:185-7.
29. Conron M, Beynon LC. Churg-Strauss syndrome. Thorax 2000;55:870-7.
30. Mosca M, Neri R, Giannessi S et al. Therapy with pulse methylprednisolone and short course pulse cyclophosphamide for diffuse proliferative glomerulonephritis. Lupus 2001;10:253-7.